페니트리움바이오 분기보고서 (2024.03)
1. 요약재무정보

1) 요약연결재무정보(단위: 원)

구분	제23기 당 분기말(2024년 03월말)	제22기 전기말(2023년 12월말)	제21기 전전기말(2022년 12월말)

[유동자산]	25,000,186,060	25,555,266,153	40,589,451,279

ㆍ현금및현금성자산	3,618,115,113	3,372,575,210	3,097,124,698

ㆍ단기금융상품	15,529,622,848	15,601,000,000	24,000,000,000

ㆍ당기손익-공정가치측정금융자산	-	-	7,972,804,866

ㆍ매출채권및기타채권	4,203,607,946	4,829,834,701	3,985,136,066

ㆍ재고자산	927,013,192	1,162,854,413	402,481,233

ㆍ기타유동자산	721,826,961	589,001,829	1,131,904,416

[비유동자산]	18,464,631,619	18,658,927,574	5,702,953,933

ㆍ관계기업투자주식	848,388,563	871,971,044	952,060,316

ㆍ당기손익-공정가치측정비유동금융자산	1,019,373,400	974,520,000	224,364,912

ㆍ유형자산	2,686,679,282	2,849,220,036	2,792,157,646

ㆍ무형자산	1,079,378,158	1,081,519,184	973,401,615

ㆍ투자부동산	11,668,602,288	11,720,483,348	-

ㆍ기타비유동자산	1,162,209,928	1,161,213,962	760,969,444

자산총계	43,464,817,679	44,214,193,727	46,292,405,212

[유동부채]	16,051,015,313	15,296,655,852	14,207,021,960

[비유동부채]	1,770,380,571	1,789,955,526	1,375,585,374

부채 총계	17,821,395,884	17,086,611,378	15,582,607,334

지배기업소유주지분	25,755,110,105	27,150,789,792	30,340,609,792

[자본금]	2,183,625,000	2,183,625,000	2,183,625,000

[자본잉여금]	20,418,648,438	20,418,648,438	20,418,648,438

[기타자본]	(3,727,104,404)	(3,727,813,651)	(3,723,279,478)

[이익잉여금]	6,879,941,071	8,276,330,005	11,461,615,832

비지배지분	(111,688,310)	(23,207,443)	369,188,086

자본 총계	25,643,421,795	27,127,582,349	30,709,797,878

관계기업 투자주식의 평가방법	지분법	지분법	지분법

2024.01.01~2024.03.31	2023.01.01~2023.12.31	2022.01.01~2022.12.31

매출액	2,932,546,806	13,790,195,699	14,882,555,787

영업이익	(1,772,388,898)	(3,464,613,885)	(754,740,449)

당기순이익	(1,484,869,801)	(3,363,294,388)	(58,882,743)

지배기업소유주지분	(1,396,388,934)	(2,970,313,225)	266,502,935

비지배지분	(88,480,867)	(392,981,163)	(325,385,678)

주당순이익	(66)	(140)	12

희석주당이익	(53)	(87)	3

2) 요약재무정보(단위: 원)

구분	제23기 당 분기말 (2024년 03월말)	제22기 전기말 (2023년 12월말)	제21기 전전기말 (2022년 12월말)

[유동자산]	26,003,886,001	26,416,763,716	39,845,619,438

ㆍ현금및현금성자산	3,508,997,583	3,326,420,831	3,084,101,544

ㆍ단기금융상품	15,529,622,848	15,601,000,000	24,000,000,000

ㆍ당기손익-공정가치측정금융자산	-	-	7,972,804,866

ㆍ매출채권및기타채권	6,135,488,054	6,775,291,022	3,726,662,122

ㆍ기타유동자산	829,777,516	714,051,863	1,062,050,906

[비유동자산]	18,102,747,417	18,179,783,943	7,078,266,068

ㆍ당기손익-공정가치측정비유동금융자산	1,019,373,400	974,520,000	224,364,912

ㆍ종속기업투자주식	1,907,636,272	1,907,636,272	3,815,272,544

ㆍ관계기업투자주식	743,773,620	743,773,620	743,773,620

ㆍ유형자산	1,305,983,311	1,368,990,257	1,461,088,871

ㆍ무형자산	289,387,766	266,663,505	64,383,068

ㆍ투자부동산	11,668,602,288	11,720,483,348	-

ㆍ기타비유동자산	1,167,990,760	1,197,716,941	769,383,053

자산총계	44,106,633,418	44,596,547,659	46,923,885,506

[유동부채]	15,760,029,075	15,144,738,418	13,934,446,459

[비유동부채]	655,386,132	661,875,854	182,535,087

부채 총계	16,415,415,207	15,806,614,272	14,116,981,546

[자본금]	2,183,625,000	2,183,625,000	2,183,625,000

[자본잉여금]	21,395,991,395	21,395,991,395	21,395,991,395

[기타자본]	(3,739,155,755)	(3,739,155,755)	(3,739,155,755)

[이익잉여금]	7,850,757,571	8,949,472,747	12,966,443,320

자본 총계	27,691,218,211	28,789,933,387	32,806,903,960

종속,관계투자주식의 평가방법	원가법	원가법	원가법

2024.01.01~2024.03.31	2023.01.01~2023.12.31	2022.01.01~2022.12.31

매출액	2,657,181,536	13,790,195,699	14,881,305,787

영업이익	(1,457,939,250)	(1,911,004,834)	516,521,349

당기순이익	(1,098,715,176)	(3,800,188,519)	1,144,040,937

주당순이익	(52)	(180)	53

희석주당이익	(40)	(124)	42